This is supported by other research demonstrating the role of NF‐κB activation in upregulating PD‐L1 in various cancers, and the involvement of miRNAs like miR‐149‐5p in regulating inflammation and immune responses via TAB2 [17]. This evidence concerns the gene NFKB1 and cancer.